BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Doaty S, Agrawal H, Bauer E, Furst DE. Infection and Lupus: Which Causes Which? Curr Rheumatol Rep. 2016;18:13. [PMID: 26951251 DOI: 10.1007/s11926-016-0561-4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 8.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Zhang S, Qiao J, Qiu M, Li X. Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection. Lupus 2022. [DOI: 10.1177/09612033221141255] [Reference Citation Analysis]
2 Ko T, Koelmeyer R, Li N, Yap K, Yeo AL, Kent J, Pellicano R, Golder V, Kitching AR, Morand E, Hoi A. Predictors of infection requiring hospitalization in patients with systemic lupus erythematosus: a time-to-event analysis. Semin Arthritis Rheum 2022;57:152099. [PMID: 36155969 DOI: 10.1016/j.semarthrit.2022.152099] [Reference Citation Analysis]
3 Preciado SM, Elsaid KA, Fawaz S, Brown L, Seoane-vazquez E, Fleming M, Wang Y. Exploratory Analysis of Outpatient Visits for US Adults Diagnosed with Lupus Erythematosus: Findings from the National Ambulatory Medical Care Survey 2006–2016. Healthcare 2022;10:1664. [DOI: 10.3390/healthcare10091664] [Reference Citation Analysis]
4 Ma L, Morel L. Loss of Gut Barrier Integrity In Lupus. Front Immunol 2022;13:919792. [DOI: 10.3389/fimmu.2022.919792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Darmarajan T, Paudel KR, Candasamy M, Chellian J, Madheswaran T, Sakthivel LP, Goh BH, Gupta PK, Jha NK, Devkota HP, Gupta G, Gulati M, Singh SK, Hansbro PM, Oliver BGG, Dua K, Chellappan DK. Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulation. Environ Sci Pollut Res Int 2022. [PMID: 35657545 DOI: 10.1007/s11356-022-20984-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zhang JQ, Zhang SX, Wang J, Qiao J, Qiu MT, Wu XY, Chen JW, Gao C, Li XF. Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection. Curr Med Res Opin 2022;:1-23. [PMID: 35414310 DOI: 10.1080/03007995.2022.2065145] [Reference Citation Analysis]
7 Rekvig OP. The Anti-DNA Antibodies: Their Specificities for Unique DNA Structures and Their Unresolved Clinical Impact-A System Criticism and a Hypothesis. Front Immunol 2021;12:808008. [PMID: 35087528 DOI: 10.3389/fimmu.2021.808008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lu Z, Tian Y, Bai Z, Liu J, Zhang Y, Qi J, Jin M, Zhu J, Li X. Increased oxidative stress contributes to impaired peripheral CD56dimCD57+ NK cells from patients with systemic lupus erythematosus. Arthritis Res Ther 2022;24:48. [PMID: 35172900 DOI: 10.1186/s13075-022-02731-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bernardo M, Martins J, Martins M, Prata F, Costa-Reis P, Ferrão A, João Palaré M. Autoimmune haemolytic anaemia following SARS-CoV-2 infection in a child: A clue to a systemic autoimmune disease. Pediatr Blood Cancer 2022;69:e29481. [PMID: 34842350 DOI: 10.1002/pbc.29481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Elfving P, Kariniemi S, Kautiainen H, Virta LJ, Kaipiainen-Seppänen O, Puolakka K. Mortality in SLE patients compared with population controls in Finland in years 2000-2015. Rheumatology (Oxford) 2021;60:4238-44. [PMID: 33404636 DOI: 10.1093/rheumatology/keaa917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
11 Zhu T, Huang Y, Qian D, Sheng Y, Zhang C, Chen S, Zhang H, Wang H, Zhang X, Liu J, Ding C, Liu L. Assessing the Function of the ZFP90 Variant rs1170426 in SLE and the Association Between SLE Drug Target and Susceptibility Genes. Front Immunol 2021;12:611515. [PMID: 33796098 DOI: 10.3389/fimmu.2021.611515] [Reference Citation Analysis]
12 Miller AL, Bessho S, Grando K, Tükel Ç. Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases. Front Immunol 2021;12:638867. [PMID: 33717189 DOI: 10.3389/fimmu.2021.638867] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
13 Park JW, Curtis JR, Lee H, Lee JK, Song YW, Lee EB. Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids. PLoS One 2020;15:e0244239. [PMID: 33382731 DOI: 10.1371/journal.pone.0244239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Fernandez-Ruiz R, Paredes JL, Niewold TB. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res 2021;232:13-36. [PMID: 33352298 DOI: 10.1016/j.trsl.2020.12.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 16.0] [Reference Citation Analysis]
15 Panda AK, Tripathy R, Das BK. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study. Lupus 2021;30:219-27. [PMID: 33176568 DOI: 10.1177/0961203320972799] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
16 Rekvig OP. Autoimmunity and SLE: Factual and Semantic Evidence-Based Critical Analyses of Definitions, Etiology, and Pathogenesis. Front Immunol 2020;11:569234. [PMID: 33123142 DOI: 10.3389/fimmu.2020.569234] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
17 Spihlman AP, Gadi N, Wu SC, Moulton VR. COVID-19 and Systemic Lupus Erythematosus: Focus on Immune Response and Therapeutics. Front Immunol 2020;11:589474. [PMID: 33193418 DOI: 10.3389/fimmu.2020.589474] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
18 Pachucki RJ, Corradetti C, Kohler L, Ghadiali J, Gallo PM, Nicastro L, Tursi SA, Gallucci S, Tükel Ç, Caricchio R. Persistent Bacteriuria and Antibodies Recognizing Curli/eDNA Complexes From Escherichia coli Are Linked to Flares in Systemic Lupus Erythematosus. Arthritis Rheumatol 2020;72:1872-81. [PMID: 32840064 DOI: 10.1002/art.41400] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
19 Seo MR, Kim J, Park E, Jung SM, Sung Y, Kim H, Kim G, Kim H, Lee M, Lee J, Hur J, Chin BS, Eom JS, Baek HJ; The Korean College of Rheumatology Working Group. Recommendations for the Management of Patients With Systemic Rheumatic Diseases During the Coronavirus Disease Pandemic. J Rheum Dis 2020;27:218-32. [DOI: 10.4078/jrd.2020.27.4.218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Seo MR, Kim JW, Park EJ, Jung SM, Sung YK, Kim H, Kim G, Kim HS, Lee MS, Lee J, Hur JA, Chin BS, Eom JS, Baek HJ; Korean College of Rheumatology working group. Recommendations for the management of patients with systemic rheumatic diseases during the coronavirus disease pandemic. Korean J Intern Med 2020;35:1317-32. [PMID: 32972125 DOI: 10.3904/kjim.2020.417] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
21 Elera-Fitzcarrald C, Ugarte-Gil MF, Alarcón GS. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America. J Clin Rheumatol 2020;26:215-7. [PMID: 32511148 DOI: 10.1097/RHU.0000000000001493] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
22 Reis AD, Mudinutti C, de Freitas Peigo M, Leon LL, Costallat LTL, Rossi CL, Costa SCB, Bonon SHA. Active human herpesvirus infections in adults with systemic lupus erythematosus and correlation with the SLEDAI score. Adv Rheumatol 2020;60:42. [PMID: 32831149 DOI: 10.1186/s42358-020-00144-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
23 Suárez-Avellaneda A, Quintana JH, Aragón CC, Gallego LM, Gallego CN, Bolaños JD, A Guerra M, Ochoa ME, Granados M, Ruiz-Ordoñez I, Tobón GJ. Systemic lupus erythematosus in the intensive care unit: a systematic review. Lupus 2020;29:1364-76. [PMID: 32723062 DOI: 10.1177/0961203320941941] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
24 Mantovani Cardoso E, Hundal J, Feterman D, Magaldi J. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology. Clin Rheumatol 2020;39:2811-5. [PMID: 32720260 DOI: 10.1007/s10067-020-05310-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 25.0] [Reference Citation Analysis]
25 Panda AK, Tripathy R, Das BK. CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: a hospital-based case-control study.. [DOI: 10.1101/2020.06.19.20136119] [Reference Citation Analysis]
26 Barber MRW, Clarke AE. Systemic lupus erythematosus and risk of infection. Expert Rev Clin Immunol 2020;16:527-38. [PMID: 32478627 DOI: 10.1080/1744666X.2020.1763793] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
27 Meara A, Lamoreaux B, Steigleman H, Yedimenko J, Jarjour W, Rovin B, Parikh S, Ayoub I, Ardoin SP. Frequency of Cytomegalovirus Seropositivity and Viremia in a Midwestern University Lupus Population. J Clin Rheumatol 2020;26:157-9. [PMID: 32453289 DOI: 10.1097/RHU.0000000000001390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Xing ZX, Yu K, Yang H, Liu GY, Chen N, Wang Y, Chen M. Successful use of plasma exchange in fulminant lupus myocarditis coexisting with pneumonia: A case report. World J Clin Cases 2020; 8(10): 2056-2065 [PMID: 32518801 DOI: 10.12998/wjcc.v8.i10.2056] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
29 Conigliaro P, Triggianese P, Ballanti E, Perricone C, Perricone R, Chimenti MS. Complement, infection, and autoimmunity. Curr Opin Rheumatol 2019;31:532-41. [PMID: 31192812 DOI: 10.1097/BOR.0000000000000633] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 21.0] [Reference Citation Analysis]
30 Wu M, Huang J, Chen H, Wei JC. Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study. Lupus 2020;29:751-60. [DOI: 10.1177/0961203320923393] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
31 Beltrán A, Mora C, Bastidas AR, Aragón Guzmán DM. Caracterización de pacientes con lupus y fiebre: actividad, infección o ambas. Revista Colombiana de Reumatología 2020;27:95-102. [DOI: 10.1016/j.rcreu.2020.01.004] [Reference Citation Analysis]
32 Wu MC, Leong PY, Chiou JY, Chen HH, Huang JY, Wei JC. Increased Risk of Systemic Lupus Erythematosus in Patients With Helicobacter pylori Infection: A Nationwide Population-Based Cohort Study. Front Med (Lausanne) 2019;6:330. [PMID: 32064263 DOI: 10.3389/fmed.2019.00330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
33 Im JH, Chung MH, Park YK, Kwon HY, Baek JH, Lee SY, Lee JS. Antinuclear antibodies in infectious diseases. Infect Dis (Lond) 2020;52:177-85. [PMID: 31718355 DOI: 10.1080/23744235.2019.1690676] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
34 Bragazzi NL, Watad A, Damiani G, Adawi M, Amital H, Shoenfeld Y. Role of anti-DNA auto-antibodies as biomarkers of response to treatment in systemic lupus erythematosus patients: hypes and hopes. Insights and implications from a comprehensive review of the literature. Expert Rev Mol Diagn 2019;19:969-78. [PMID: 31516059 DOI: 10.1080/14737159.2019.1665511] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Illescas-Montes R, Corona-Castro CC, Melguizo-Rodríguez L, Ruiz C, Costela-Ruiz VJ. Infectious processes and systemic lupus erythematosus. Immunology 2019;158:153-60. [PMID: 31386190 DOI: 10.1111/imm.13103] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 12.0] [Reference Citation Analysis]
36 Cui J, Yan W, Xie H, Xu S, Wang Q, Zhang W, Ni A. Cytomegalovirus antigenemia in patients with autoimmune and non-autoimmune diseases in Beijing: A 10-year single hospital experience. PLoS One 2019;14:e0221793. [PMID: 31461496 DOI: 10.1371/journal.pone.0221793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Rekvig OP. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be. Front Immunol 2019;10:1104. [PMID: 31156647 DOI: 10.3389/fimmu.2019.01104] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
38 Lu Z, Li J, Ji J, Gu Z, Da Z. Altered peripheral lymphocyte subsets in untreated systemic lupus erythematosus patients with infections. Braz J Med Biol Res 2019;52:e8131. [PMID: 30994732 DOI: 10.1590/1414-431X20198131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
39 Lu Z, Li J, Ji J, Gu Z, Da Z. Mortality prediction in systemic lupus erythematosus patients with pulmonary infection. Int J Rheum Dis 2019;22:1077-83. [PMID: 30968568 DOI: 10.1111/1756-185X.13555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
40 Harry O, Yasin S, Brunner H. Childhood-Onset Systemic Lupus Erythematosus: A Review and Update. J Pediatr 2018;196:22-30.e2. [PMID: 29703361 DOI: 10.1016/j.jpeds.2018.01.045] [Cited by in Crossref: 47] [Cited by in F6Publishing: 33] [Article Influence: 15.7] [Reference Citation Analysis]
41 Higgins GC. Complications of Treatments for Pediatric Rheumatic Diseases. Pediatr Clin North Am 2018;65:827-54. [PMID: 30031500 DOI: 10.1016/j.pcl.2018.04.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
42 Balbi GGM, Machado-ribeiro F, Marques CD, Signorelli F, Levy RA. The interplay between tuberculosis and systemic lupus erythematosus. Current Opinion in Rheumatology 2018;30:395-402. [DOI: 10.1097/bor.0000000000000493] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
43 Tang K, Tseng C, Hsieh T, Chen D. Induction therapy for membranous lupus nephritis: a systematic review and network meta-analysis. Int J Rheum Dis 2018;21:1163-72. [DOI: 10.1111/1756-185x.13321] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
44 Macauley P, Rapp M, Park S, Lamikanra O, Sharma P, Marcelin M, Sharma K. Miliary Tuberculosis Presenting With Meningitis in a Patient Treated With Mycophenolate for Lupus Nephritis: Challenges in Diagnosis and Review of the Literature. J Investig Med High Impact Case Rep 2018;6:2324709618770226. [PMID: 29707591 DOI: 10.1177/2324709618770226] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
45 Draborg AH, Rasmussen NS, Larsen JL, Jørgensen CS, Sandhu N, Skogstrand K, Jacobsen S, Houen G. Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status. PLoS One 2018;13:e0193244. [PMID: 29499037 DOI: 10.1371/journal.pone.0193244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
46 Rekvig OP. Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas. Front Immunol 2018;9:387. [PMID: 29545801 DOI: 10.3389/fimmu.2018.00387] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
47 Gendelman O, Mahroum N, Comaneshter D, Rotman-Pikielny P, Cohen AD, Amital H, Sherf M. Hepatitis B carrier state among SLE patients: case-control study. Immunol Res 2017;65:257-61. [PMID: 27423436 DOI: 10.1007/s12026-016-8834-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
48 Ragab G, Dehner C, Hamza H, Kriegel M. Systemic Lupus Erythematosus. The Microbiome in Rheumatic Diseases and Infection 2018. [DOI: 10.1007/978-3-319-79026-8_21] [Reference Citation Analysis]
49 Kaparakis-liaskos M, D’elios MM. Helicobacter pylori: Immune Responses and Gastric Autoimmunity. The Microbiome in Rheumatic Diseases and Infection 2018. [DOI: 10.1007/978-3-319-79026-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Zhan Z, Lao M, Su F, Chen D, Liang L, Yang X. Hospital-acquired infection in patients with systemic lupus erythematosus: a case-control study in a southern Chinese population. Clin Rheumatol 2018;37:709-17. [DOI: 10.1007/s10067-017-3919-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
51 Nagel J, Saxne T, Geborek P, Bengtsson AA, Jacobsen S, Svaerke Joergensen C, Nilsson JÅ, Skattum L, Jönsen A, Kapetanovic MC. Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine. Lupus 2017;26:1072-81. [PMID: 28420056 DOI: 10.1177/0961203317695465] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
52 Nikitakis NG, Papaioannou W, Sakkas LI, Kousvelari E. The autoimmunity-oral microbiome connection. Oral Dis 2017;23:828-39. [PMID: 27717092 DOI: 10.1111/odi.12589] [Cited by in Crossref: 38] [Cited by in F6Publishing: 90] [Article Influence: 6.3] [Reference Citation Analysis]